Atlas Trials

Study on the Pathogenesis of Retinal Vascular Diseases Based on Body Fluid Metabolomics

Clinical trial NCT06408571 · UNKNOWN

Trial details

NCT number
NCT06408571
Sponsor
Zhongnan Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Metabolomics; Retinopathy; Etiology
Start date
2023-09-07
Primary completion
2024-10-30
Enrollment
3900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.